OpenVSafe by OpenVAERS
Search V-safe

9UK-18484-21717

4 vaccinations 7 coded responses 32 check-ins 6 free-text entries 2 call cases
Sex
Male
Age at first dose
66+
ZIP prefix
985 / WA
Registered
2021-02-05
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
1670778 (opens in a new window) high 10 / 11 -1 4 of 9 VAERS symptoms same dose (2) WA matches 2021-02-25 / 2021-08-16 / 2021-09-03
received the same day as the last call
case 968722

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-02-04
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-05
    Registered in v-safe
  3. 2021-02-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-02-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-02-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-02-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-10
    Survey response — days 1–6 daily, dose 1
    MedDRA: Cough — Feeling: Good · Headache
    Free text: Cough
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-02-11
    Survey response — day 7, dose 1
    MedDRA: Cough — Feeling: Good · Headache, Fatigue or tiredness
    Free text: Cough
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-02-19
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-25
    Dose 2 — Pfizer-BioNTech
  12. 2021-02-25
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-02-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  14. 2021-02-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-02-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  16. 2021-03-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-03-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-03-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-03-04
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-03-11
    Survey response — day 14, dose 2
    MedDRA: Arrhythmia, Fatigue, Heart rate decreased, Hypotension, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities
    Free text: I have Hx of permanent A-fib with Rx. On Monday I was hypotensive with unusually low heart rate. I have experienced fatique and apparent increased arrhythmias the past 4 days.While disconcerting, I do not contribute this to the vaccine.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-03-18
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-25
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-01
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-08
    Survey response — day 42, dose 2
    MedDRA: Asthenia, Atrial fibrillation, Headache, Seasonal allergy — Feeling: Good · Be unable to do your normal daily activities
    Free text: Increased incidence of moderate headaches. Continued low energy level which I now believe to be atypical. BUT both of above may be associated with seasonal allergy or underlying cardiac status (permanent atrial fibrillation).
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-05-28
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-08-26
    Survey response — 6 months, dose 2
    MedDRA: Atrial fibrillation, Headache, Heart rate decreased, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Increased symptoms/ issues associated with preexisting A-fib. Specifically, increased range of heart rate, with alarming lows (<40 BPM).Chronic low grade headache.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  27. 2021-08-26
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  28. 2021-09-02
  29. 2021-09-03
  30. 2021-09-03
  31. 2021-09-03
    Call successful
    Completed over the phone
  32. 2021-10-06
    Dose 3 — Pfizer-BioNTech
  33. 2022-02-25
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  34. 2022-03-30
    Dose 4 — Pfizer-BioNTech
  35. 2022-04-19
    Survey response — day 14, dose 4
    MedDRA: Fatigue, Headache — Feeling: Good
    Free text: Headaches, fatigue
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-04-20
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  37. 2022-04-27
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  38. 2022-05-04
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  39. 2022-05-11
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  40. 2022-06-29
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  41. 2022-09-28
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in
  42. 2023-04-01
    Survey response — 12 months, dose 4
    MedDRA: Atrial fibrillation, Dyspnoea, Gastrointestinal haemorrhage, Peripheral swelling, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11
  43. 2023-04-01
    Report sent to call center — 12 months, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  44. 2023-04-03
    Call successful
    Completed over the phone

Vaccinations

DoseDateManufacturerCo-administered
12021-02-04Pfizer-BioNTech
22021-02-25Pfizer-BioNTech
32021-10-06Pfizer-BioNTech No
42022-03-30Pfizer-BioNTech No

Call center

2 call center cases

2 successful

VAERS report filed, before or during a call: 2

See the call center timeline

Free text

Release 4 — days 1–6 daily, dose 1

2021-02-10

Systemic reaction (other): Cough

Release 4 — day 7, dose 1

2021-02-11

Systemic reaction (other): Cough

Release 5 — day 14, dose 2

2021-03-11

Symptoms: I have Hx of permanent A-fib with Rx. On Monday I was hypotensive with unusually low heart rate. I have experienced fatique and apparent increased arrhythmias the past 4 days.While disconcerting, I do not contribute this to the vaccine.

Release 7 — day 42, dose 2

2021-04-08

Symptoms: Increased incidence of moderate headaches. Continued low energy level which I now believe to be atypical. BUT both of above may be associated with seasonal allergy or underlying cardiac status (permanent atrial fibrillation).

Release 9 — 6 months, dose 2

2021-08-26

Symptoms: Increased symptoms/ issues associated with preexisting A-fib. Specifically, increased range of heart rate, with alarming lows (<40 BPM).Chronic low grade headache.

Release 11 — day 14, dose 4

2022-04-19

Symptoms: Headaches, fatigue

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArrhythmia ✓ ✓ ✓
SDAsthenia ✓ ✓ ✓
SDAtrial fibrillation ✓ ✓ ✓
SDDyspnoea · · ✓
SDFatigue ✓ ✓ ✓
SDGastrointestinal haemorrhage · · ✓
SDHeadache ✓ ✓ ✓
SDHeart rate decreased ✓ ✓ ✓
SDHypotension ✓ ✓ ✓
SDPeripheral swelling · · ✓
SDPre-existing disease ✓ ✓ ✓
SDSeasonal allergy ✓ ✓ ✓
SROCough ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release